Pirro, F. et al. 2025. Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy. Dermatology Practical & Conceptual. 15, 1 (Jan. 2025), 4838. DOI:https://doi.org/10.5826/dpc.1501a4838.